CIBC Private Wealth Group
ZVRA icon

CIBC Private Wealth Group’s Zevra Therapeutics ZVRA Stock Holding History

CIBC Private Wealth Group’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$4.03K Hold
450
– – ﹤0.01% 2673
2025
Q3 		$4.28K Hold
450
– – ﹤0.01% 2599
2025
Q2 		$3.96K Hold
450
– – ﹤0.01% 2499
2025
Q1 		$2.97K Hold
450
– – ﹤0.01% 2595
2024
Q4 		$3.84K Hold
450
– – ﹤0.01% 2557
2024
Q3 		$3.12K Hold
450
– – ﹤0.01% 2719
2024
Q2 		$2.02K Hold
450
– – ﹤0.01% 2755
2024
Q1 		$2.32K Buy
+450
New +$2.77K ﹤0.01% 2718

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

CIBC Private Wealth Group's ZVRA Position: Q4 2025 in Review

CIBC Private Wealth Group held its Zevra Therapeutics (ZVRA) position steady in Q4 2025 at 450 shares worth $4.03K. The position accounts for ﹤0.01% of the portfolio, ranked #2673.

CIBC Private Wealth Group first reported a position in ZVRA in Q1 2024 and has held it in 8 quarters since. The position peaked at $4.28K in Q3 2025. 158 funds tracked by Wall St. Rank hold ZVRA as of Q4 2025.

  • CIBC Private Wealth Group held 450 shares of Zevra Therapeutics worth $4.03K as of Q4 2025.
  • CIBC Private Wealth Group left its Zevra Therapeutics share count unchanged in Q4 2025.
  • Zevra Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2673 holding.
  • CIBC Private Wealth Group first reported a position in Zevra Therapeutics in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's Zevra Therapeutics position peaked at $4.28K in Q3 2025.
  • 158 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.